Table 4.
HLA match | |||||
---|---|---|---|---|---|
Matched | 1 allele mismatch | 2 allele mismatch | 3 allele mismatch | ≥4 allele mismatch | |
Number | 46 | 63 | 88 | 105 | 69 |
Graft failure | 19 (41%) | 29 (46%) | 42 (48%) | 43 (41%) | 27 (39%) |
Graft versus host disease | 1 (2%) | 4 (6%) | 3 (3%) | 11 (10%) | 7 (10%) |
Interstitial pneumonitis | 5 (11%) | 3 (5%) | 6 (7%) | 8 (8%) | 4 (6%) |
Infection | 8 (17%) | 4 (6%) | 7 (8%) | 12 (11%) | 10 (14%) |
Organ failure | 7 (15%) | 10 (16%) | 14 (16%) | 14 (13%) | 11 (16%) |
Haemorrhage | 1 (2%) | 3 (5%) | 5 (6%) | 6 (6%) | 2 (3%) |
Progressive disease* | 2 (4%) | 2 (3%) | 5 (6%) | 3 (3%) | 1 (1%) |
EBV-PTLD | – | – | 2 (2%) | 1 (1%) | 1 (1%) |
Other | 2 (4%) | 4 (6%) | 1 (1%) | 2 (2%) | 2 (3%) |
Not reported | 1 (2%) | 4 (6%) | 3 (3%) | 5 (5%) | 4 (6%) |
Number in parenthesis = column percent
Death from progression of primary disease despite donor chimerism ≥95%: Tay-Sachs, Sanfilipo, globoid cell leukodystrophy, metachromatic leukodystrophy and adrenoleukodystrophy
EBV-PTLD = Ebstein-Barr post transplant lymphoproliferative disease